Definition of the canonical TCR pairs expressed by CD8 Tregs also opens the possibility of selective activation or deletion of these MHC-E–restricted CD8 Tregs by antibodies specific for these TCRs and modulation of their activity in pathologic conditions that include autoimmune diseases and cancers. This evidence concerns the gene CD8A and cancer.